Health care utilization and expenditures for children and young adults with muscular dystrophy in a privately insured population

被引:39
作者
Ouyang, Lijing [1 ]
Grosse, Scott D. [1 ]
Kenneson, Aileen [1 ]
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA
关键词
neuromuscular disease; medical care; cost; muscular dystrophy; Duchenne;
D O I
10.1177/0883073808314962
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We provide estimates of medical care utilization and expenditures for children and young adults younger than age 30 with muscular dystrophies in the United States. Accurate estimates are essential for calculations of lifetime costs and for economic evaluations of screening and management strategies for muscular dystrophy. We compare the medical expenditures for persons with muscular dystrophy with others by age groups. The incremental annual expenditures of medical care for privately insured individuals with Muscular dystrophy relative to others in 2004 averaged $ 18 930 and ranged from $13 464 at ages 5 to 9 to $32 541 at ages 15 to 19. Individuals with muscular dystrophy had average medical expenditures 10 to 20 times greater than individuals without muscular dystrophy. Individuals aged 15 to 19 years had the highest number of inpatient admissions related to respiratory infections and cardiac complications. The findings underscore the need for appropriate treatment options for individuals with Muscular dystrophy as they age.
引用
收藏
页码:883 / 888
页数:6
相关论文
共 9 条
  • [1] [Anonymous], 2005, Curr Paediatr, DOI 10.1016/j.cupe.2005.04.001.4D
  • [2] Nonmolecular treatment for muscular dystrophies
    Bushby, K
    Straub, V
    [J]. CURRENT OPINION IN NEUROLOGY, 2005, 18 (05) : 511 - 518
  • [3] The muscular dystrophies
    Emery, AEH
    [J]. LANCET, 2002, 359 (9307) : 687 - 695
  • [4] Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid Program, fiscal year 1993
    Ireys, HT
    Anderson, GF
    Shaffer, TJ
    Neff, JM
    [J]. PEDIATRICS, 1997, 100 (02) : 197 - 204
  • [5] Trends and racial disparities in muscular dystrophy deaths in the United States, 1983-1998: An analysis of multiple cause mortality data
    Kenneson, Aileen
    Kolor, Katherine
    Yang, Quanhe
    Olney, Richard S.
    Rasmussen, Sonja A.
    Friedman, J. M.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (21) : 2289 - 2297
  • [6] *MEDST GROUP INC, 2003, MARKETSCAN DAT
  • [7] Practice parameter: Corticosteroid treatment of Duchenne dystrophy - Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
    Moxley, RT
    Ashwal, S
    Pandya, S
    Connolly, A
    Florence, J
    Mathews, K
    Baumbach, L
    McDonald, C
    Sussman, M
    Wade, C
    [J]. NEUROLOGY, 2005, 64 (01) : 13 - 20
  • [8] A national profile of health care utilization and expenditures for children with special health care needs
    Newacheck, PW
    Kim, SE
    [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2005, 159 (01): : 10 - 17
  • [9] Papazian Oscar, 2002, Adolesc Med, V13, P511